Publications by authors named "Mayuko Ori"

Claim this Profile
A
A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.
Narihiro Toda, Keiko Tago, Shinji Marumoto, Kazuko Takami, Mayuko Ori

Bioorg Med Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.
Yasuyuki Abe, Atsushi Aoyagi, Takao Hara, Kazumi Abe, Reina Yamazaki, Mayuko Ori

J Pharmacol Sci· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereospecific construction of contiguous quaternary and tertiary stereocenters by rearrangement from indoline-2-methanol to 2,2,3-trisubstituted tetrahydroquinoline: application to an efficient total synthesis of natural virantmycin.
Mayuko Ori, Narihiro Toda, Kazuko Takami, Keiko Tago, Hiroshi Kogen

Angew Chem Int Ed Engl· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and structure-activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.
Narihiro Toda, Keiko Tago, Shinji Marumoto, Kazuko Takami, Mayuko Ori

Bioorg Med Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total synthesis of (+)-benzastatin E via diastereoselective Grignard addition to 2-acylindoline.
Narihiro Toda, Mayuko Ori, Kazuko Takami, Keiko Tago, Hiroshi Kogen

Org Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease.
Hiroshi Kogen, Narihiro Toda, Keiko Tago, Shinji Marumoto, Kazuko Takami, Mayuko Ori

Org Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis